MetLife Investment Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1529735
Whippany, NJ
Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$42,522,623
+$4,023,627 QoQ
Shares Held
305,106
-2.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. GILD ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,522,623 | 305,106 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $38,498,996 | 313,663 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $35,943,687 | 323,817 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $36,835,892 | 332,244 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $36,274,058 | 323,731 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,472,678 | 329,898 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,146,469 | 323,789 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,802,533 | 332,350 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,376,401 | 291,828 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $24,510,790 | 302,565 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,102,428 | 308,279 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $24,404,600 | 316,655 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $26,716,174 | 321,998 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,124,030 | 327,595 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $20,526,792 | 332,741 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $20,888,009 | 337,939 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $20,292,722 | 341,341 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $20,123,571 | 277,146 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $21,526,722 | 308,185 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $20,022,766 | 290,775 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $21,000,096 | 324,928 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $17,735,858 | 304,426 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $20,086,394 | 317,873 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $25,233,780 | 327,967 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $24,379,759 | 326,107 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||